Genmab has signed an agreement to buy all shares of Merus at $97 per share, in an all-cash transaction valued at $8bn.

An Indian woman who documented her months-long job hunting journey on social media has now left the United States after failing to land a suitable role.

U.S. life sciences major Thermo Fisher Scientific and the Department for Promotion of Industry and Internal Trade (DPIIT) ...

Another life sciences company has come out to assure its shareholders the new US tariff on drugs won't affect it. The post ...

Two drug development agreements in under a month have caused this junior biotech's shares to surge. The post This ...

One of the NCBiotech portfolio companies there is Elysia Bio, founded in 2021 by Raleigh native and CEO Eli Hornstein, Ph.D.

In a Truth Social post, Trump noted that the White House would place a 100% tariff on “any branded or patented” pharmaceutical product — unless a company was investing in manufacturing facilities in ...

For therapeutics companies that have transitioned out of the lab and onto a commercialization path, Triangle Venture Day is a ...

Chicago-based Aspen Dental partnered with Forward Science, an oral health-focused biotechnology company, to add PerioStōm, a non-drug periodontal therapy to its practices. PerioStōm is an FDA-approved ...

A team led by UCL (University College London) and Imperial College London researchers has shown for the first time how ...

In subtle and not-so-subtle ways, today’s bioeconomy touches nearly every aspect of our lives. And new technologies and ...

Industry representatives have voiced their support for the Biotech Act, hoping it will improve financing and institutional support of IVD makers.